Island Pharmaceuticals Ltd (ILA)

Currency in AUD
0.21
+0.01(+4.88%)
Closed·
ILA Scorecard
Full Analysis
Significant return over the last week
Earnings results expected in 11 days
ILA is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
0.190.22
52 wk Range
0.060.28
Key Statistics
Bid/Ask
0.21 / 0.21
Prev. Close
0.21
Open
0.2
Day's Range
0.19-0.22
52 wk Range
0.06-0.28
Volume
1.03M
Average Volume (3m)
708.3K
1-Year Change
204.35%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ILA Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Suffers from weak gross profit margins

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Island Pharmaceuticals Ltd Company Profile

Island Pharmaceuticals Limited, a drug research and repurposing company, focuses on the development of preventative or therapeutic drugs for viral infections in Australia and the United States of America. Its lead product candidate is ISLA-101, a drug for the prevention and treatment of dengue fever and other mosquito borne diseases. The company has a collaboration agreement with Monash University and National Cancer Institute IND. It also has a cooperative research and development agreement with the U.S. Army, Island in preparation for its Phase 2a/b clinical study for ISLA-101. Island Pharmaceuticals Limited was founded in 2017 and is based in Camberwell, Australia.

Compare ILA to Peers and Sector

Metrics to compare
ILA
Peers
Sector
Relationship
P/E Ratio
−16.0x−3.3x−0.5x
PEG Ratio
−1.89−0.010.00
Price/Book
13.3x1.5x2.6x
Price / LTM Sales
130.0x8.1x3.3x
Upside (Analyst Target)
84.5%223.8%43.4%
Fair Value Upside
Unlock26.2%7.1%Unlock

Earnings

Latest Release
May 28, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
EPS Revisions
Last 90 days

ILA Income Statement

FAQ

What Stock Exchange Does Island Pharmaceuticals Trade On?

Island Pharmaceuticals is listed and trades on the Sydney Stock Exchange stock exchange.

What Is the Stock Symbol for Island Pharmaceuticals?

The stock symbol for Island Pharmaceuticals is "ILA."

What Is the Island Pharmaceuticals Market Cap?

As of today, Island Pharmaceuticals market cap is 51.92M.

What Is Island Pharmaceuticals's Earnings Per Share (TTM)?

The Island Pharmaceuticals EPS (TTM) is -0.03.

When Is the Next Island Pharmaceuticals Earnings Date?

Island Pharmaceuticals will release its next earnings report on 20 Aug 2025.

From a Technical Analysis Perspective, Is ILA a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Island Pharmaceuticals Stock Split?

Island Pharmaceuticals has split 0 times.

How Many Employees Does Island Pharmaceuticals Have?

Island Pharmaceuticals has 0 employees.

What is the current trading status of Island Pharmaceuticals (ILA)?

As of 10 Aug 2025, Island Pharmaceuticals (ILA) is trading at a price of 0.21, with a previous close of 0.21. The stock has fluctuated within a day range of 0.19 to 0.22, while its 52-week range spans from 0.06 to 0.28.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.